Do Peritoneal Nebulization of Ropivacaine Reduce the Use of Morphine After Short Gynecologic Laparoscopic Surgery?
In a recent study the investigators found that nebulization of Ropivacaine 30 mg before or
after gynaecologic laparoscopic surgery significantly reduces postoperative pain and
postoperative morphine consumption.
Ropivacaine was effectively administered with non-heating nebulizers (AeronebPro®).
However, almost all patients still use morphine after surgery.
The investigators hypothesize that intraperitoneal nebulization of Ropivacaine 150 mg may
prevent the use of morphine after the laparoscopic ovarian cyst surgery.
Interventional
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator, Outcomes Assessor), Primary Purpose: Treatment
Morphine consumption (mg)
The total dose of morphine at every evaluation after awakening will be quantified using the PACU clinical chart and/or PCA infusers memory display.
Up to 24 hours
No
Pablo M Ingelmo, MD
Principal Investigator
San Gerardo Hospital, Monza. Italy
Italy: Ethics Committee
AR HSG 02 2010 Ovarian Cyst
NCT01142622
April 2010
December 2012
Name | Location |
---|